Feedback
KOTAKBANK 
Reputation: 642,681 • Aug 17, 2023 8:31 PM
Concord Biotech to list on Friday. Here’s what GMP suggests
Analysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which comprises many niche biopharma products
The Economic Times
Vote
Comment
6 Shares
NSE:KOTAKBANK price when posted: 1,765.2